Buyout giants in talks with Wockhardt for domestic formulations business

The individual suitors have indicated that they are interested in buying at least 51% stake in a deal that could value the biz at Rs 4,000-4,500 crore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XnZ9jm
via IFTTT